Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibitor Actemra ...